Last reviewed · How we verify
Total intravenous anesthesia with Byfavo — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Total intravenous anesthesia with Byfavo (Total intravenous anesthesia with Byfavo) — Yonsei University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Total intravenous anesthesia with Byfavo TARGET | Total intravenous anesthesia with Byfavo | Yonsei University | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Total intravenous anesthesia with Byfavo CI watch — RSS
- Total intravenous anesthesia with Byfavo CI watch — Atom
- Total intravenous anesthesia with Byfavo CI watch — JSON
- Total intravenous anesthesia with Byfavo alone — RSS
Cite this brief
Drug Landscape (2026). Total intravenous anesthesia with Byfavo — Competitive Intelligence Brief. https://druglandscape.com/ci/total-intravenous-anesthesia-with-byfavo. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab